American Beacon Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
American Beacon Advisors's LLY Position: Q4 2017 in Review
American Beacon Advisors sold out of Eli Lilly (LLY) in Q4 2017, closing a stake of 815 shares — an estimated $70K sold.
American Beacon Advisors first reported a position in LLY in Q1 2017 and held it in 3 quarters. The position peaked at $70K in Q3 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.
- American Beacon Advisors reported no remaining Eli Lilly position as of Q4 2017 after selling out during the quarter.
- American Beacon Advisors sold 815 Eli Lilly shares in Q4 2017, an estimated $70K.
- American Beacon Advisors first reported a position in Eli Lilly in Q1 2017 and held it in 3 quarters.
- American Beacon Advisors's Eli Lilly position peaked at $70K in Q3 2017.
- 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.
Based on American Beacon Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.